Testicular cancer Treatment in Uni-asia Cancer hospital

Testicular cancer treatment at Uni-Asia Cancer Hospital in Chengdu, China, is led by specialists with international training and over 30 years of oncology experience. Costs for medical care at the hospital range from around $150 for an online consultation to $1,300 for a PET/CT or a whole-body CT scan. The facility is known for being the first in China to perform NanoKnife ablation and uses an expert team from the country's top hospitals.

Advanced diagnostics for testicular cancer

The diagnostic process begins with confirming the tumor type and checking if the cancer has spread. Patients can access these tests to build an accurate treatment plan:

• Online consultation with oncologist. An initial review of the case costs around $150.
• Serum tumor markers. Testing for AFP, β-hCG, and LDH levels to identify the cancer subtype.
• Scrotal ultrasound. Imaging to examine the testicles for abnormalities.
• Imaging studies. Contrast-enhanced CT scans of the chest, abdomen, and pelvis or a PET/CT scan, which costs around $1,300.

Surgical and minimally invasive treatments

Prof. Dr. Liao Zhengyin leads the oncology efforts with over 30 years of experience and 100,000+ procedures performed. A former director at West China Hospital and a visiting scholar at Johns Hopkins Hospital, Prof. Dr. Liao Zhengyin specializes in minimally invasive interventional oncology. The clinic offers several surgical and ablation methods:

• Radical inguinal orchiectomy. This open surgery is the primary step for both diagnosis and treatment.
• Retroperitoneal lymph node dissection. This procedure removes lymph node metastases and is available as open or minimally invasive surgery.
• Image-guided ablation. Using radiofrequency, microwave, or cryoablation to treat small residual nodes without reoperation.
• NanoKnife therapy. A specialized method for destroying tumor cells while protecting surrounding healthy tissue.

Therapies for advanced and resistant cases

For patients with advanced or relapsed disease, the hospital provides systemic treatments and transplant options. Testicular cancer shows a 95% survival rate at five years for early stages, and these methods help maintain high success rates even in complex cases:

• Chemotherapy and radiotherapy. Adjuvant sessions prevent recurrence after surgery, while systemic cycles treat metastatic disease.
• Targeted therapy and immunotherapy. The hospital uses immune checkpoint inhibitors for cases resistant to standard care.
• High-dose chemotherapy with stem cell transplantation. This approach serves patients with relapsed or refractory testicular cancer.

To learn more about these treatment options or to schedule an evaluation, you can request a consultation through Bookimed.